irritable bowel syndrome (IBS)

An artists rendition of the brain and the intestines in neon blue outlines connected by lines
MedTech

NeurAxis’ IB-Stim improves GI disorder pain: study

After using IB-Stim for a month, patients charted “significant reductions” in abdominal pain, nausea and functional disability.
Andrea Park Sep 13, 2023 2:27pm
Melbourne

Anatara, ObvioHealth partner for virtual trials in Australia

Oct 4, 2021 12:52pm
person holding smartphone

Mahana Therapeutics rakes in $61M for IBS treatment app

Aug 11, 2021 12:05pm
Arena Pharmaceuticals

Arena fails phase 2b, prompting review of 'strategic options'

Mar 3, 2021 7:40am
Urovant

Urovant's vibegron flunks irritable bowel syndrome phase 2

Nov 25, 2020 7:45am
stop sign knerri61Pixabay

Synthetic Biologics cans phase 2 IBS trial deemed likely to fail

Oct 2, 2020 10:25am